Cwm LLC Purchases 45,433 Shares of Agilent Technologies, Inc. $A

Cwm LLC grew its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 358.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,096 shares of the medical research company's stock after acquiring an additional 45,433 shares during the quarter. Cwm LLC's holdings in Agilent Technologies were worth $6,856,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Stone House Investment Management LLC bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $30,000. Ransom Advisory Ltd bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $32,000. Central Pacific Bank Trust Division bought a new stake in Agilent Technologies during the second quarter worth $33,000. Zions Bancorporation National Association UT bought a new stake in Agilent Technologies during the first quarter worth $38,000. Finally, Costello Asset Management INC bought a new stake in Agilent Technologies during the first quarter worth $47,000.

Agilent Technologies Stock Up 0.8%

Shares of NYSE:A opened at $139.14 on Thursday. The company has a market capitalization of $39.45 billion, a PE ratio of 32.66, a price-to-earnings-growth ratio of 4.51 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The business has a fifty day moving average price of $126.49 and a two-hundred day moving average price of $117.46. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's dividend payout ratio is currently 23.24%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on A shares. Wells Fargo & Company upped their price target on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a report on Monday, September 15th. Evercore ISI upped their price target on Agilent Technologies from $128.00 to $140.00 and gave the stock an "in-line" rating in a report on Tuesday, October 7th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Friday, October 3rd. Barclays upped their price target on Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating in a report on Thursday, October 2nd. Finally, JPMorgan Chase & Co. upped their price target on Agilent Technologies from $155.00 to $165.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.